Cargando…
Immunopathological events surrounding IL-6 and IFN-α: A bridge for anti-lupus erythematosus drugs used to treat COVID-19
With the outbreak and rapid spread of COVID-19, the world health situation is unprecedentedly severe. Systemic lupus erythematosus (SLE) is a common autoimmune disease, which can cause multiple organ damage. Numerous studies have shown that immune factors have important roles in the pathogenesis of...
Autores principales: | Zhou, Bangyi, Li, Siying, Ye, Jujian, Liu, Yi, Hu, Longtai, Tang, Yan, Wu, Zhijian, Zhang, Peidong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8527889/ https://www.ncbi.nlm.nih.gov/pubmed/34710657 http://dx.doi.org/10.1016/j.intimp.2021.108254 |
Ejemplares similares
-
Possible mechanisms of cholesterol elevation aggravating COVID-19
por: Tang, Yan, et al.
Publicado: (2021) -
Impact of IL-34, IFN-α and IFN-λ1 on activity of systemic lupus erythematosus in Egyptian patients
por: Adel, Yasmin, et al.
Publicado: (2020) -
A pathogenic IFNα, BLyS and IL-17 axis in Systemic Lupus Erythematosus patients
por: López, Patricia, et al.
Publicado: (2016) -
Identification of Peptides as Novel Inhibitors to Target IFN-γ, IL-3, and TNF-α in Systemic Lupus Erythematosus
por: Mustafa, Ghulam, et al.
Publicado: (2021) -
Serology of Lupus Erythematosus: Correlation between Immunopathological Features and Clinical Aspects
por: Cozzani, Emanuele, et al.
Publicado: (2014)